Q2 2024 Inspire Medical Systems Inc Earnings Call Transcript
Key Points
- Inspire Medical Systems Inc (INSP) reported a 30% increase in revenue for Q2 2024, reaching $195.9 million compared to the same period in 2023.
- The company has expanded its market presence with 81 new implanting centers in the US and 12 new US sales territories.
- Inspire Medical Systems Inc (INSP) achieved EU MDR certification in Europe, including full-body MRI compatibility, which is a significant milestone.
- The company received FDA approval for the Inspire V neurostimulation system, which is expected to reduce surgical times and production costs.
- Inspire Medical Systems Inc (INSP) announced a $150 million share repurchase authorization, the first in the company's history, reflecting confidence in its financial performance and long-term outlook.
- Despite the strong revenue growth, the company faces challenges with maintaining consistent quarterly performance, as noted by analysts.
- Operating expenses increased by 12% year-over-year, primarily due to the expansion of the sales organization and increased general corporate costs.
- There is a potential risk of disruption or an air pocket in patient flow as patients on GLP-1 therapy may wait to see if their apnea resolves before opting for Inspire therapy.
- The company deactivated 12 centers in Q2 2024, which could indicate challenges in maintaining active and productive centers.
- There is uncertainty around the pricing strategy for the Inspire V system, and the company has not yet determined whether there will be a price increase.
Good afternoon. My name is Dilem and I'll be your conference operator today. At this time, I would like to welcome everyone to the Inspire Medical Systems second quarter 2024 conference call. (Operator Instructions) I'll now hand the call over to your first speaker, Ezgi Yagci, the Vice President of Investor Relations at Inspire. You may begin the conference.
Thank you, Dilem, and thank you all for participating in today's call. Joining me are Tim Herbert, Chairman and Chief Executive Officer, and Rick Buchholz, Chief Financial Officer. Earlier today, we released financial results for the three and six months ended June 30, 2024. A copy of the press release is available on our website.
On this call, management will make forward-looking statements within the meaning of the Federal Securities Laws of forward-looking statements, including without limitation, those relating to our operations, financial results, and financial condition investments in our business, full year 2024
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
